A 6.8% CAGR from 2014 to 2020 is extremely positive for the global collagen peptide market, as it means the market’s value will reach to US$1.1 billion by the end of 2020, from a 2013 value of US$0.7 billion. At the same time, a 7.5% CAGR during the same timeframe for the global gelatin market means it will reach a market value of US$3 billion in 2020, up from its 2013 value of US$1.8 billion. The reason for this optimistic growth rate is a series of remarkable scientific breakthroughs in the global collagen peptide and gelatin market that have pushed it into many fields, mainly food and beverages and the medical industry.

The APAC Connection
Let’s look at the global collagen peptide and gelatin market from a geographical perspective, with Europe, North America, Asia Pacific, and the Rest of the World as key segments. The global collagen peptide and gelatin market is led by North America, which dominated the market in 2013 thanks to heavy emphasis in the region on developmental and innovation. Europe follows in the global collagen peptide market owing to high penetration of the collagen peptide and gelatin into the food and beverages industry in terms of use and R&D.

Then there’s Asia Pacific, a region that is showing itself to be a real powerhouse of development. Armed with a rapid rate of industrialization, growing levels of health consciousness, and the speedy adoption of new technologies into the food and beverages and medical industries, the global collagen peptide and gelatin market could have found its prime location for the next few years. An increasing number of people, within a rapidly increasing population, are getting interested in the nutritional foods segment. Add to that a rising number of families and individuals with high disposable incomes and you get a market that’s only begun to grow.

What Makes the Global Collagen Peptide and Gelatin Market Tick?
One of the most innovative fields that make use of the global collagen peptide and gelatin market is regenerative medicine. NEDO, a Japanese healthcare company, has announced an investment of 2.5 billion yen in multiple medical projects, one of them being regenerative medicine. This is where it gets interesting: the project will make use of collagen as well as 3D printers to create artificial organs. The project will use biomaterials called recombinant peptides (RCP), synthetic proteins developed by Fujifilm Co.

Fujifilm is making headway in other fields as well; the company has made use of RCP in regenerative medicine to improve the rate of survival of transplanted cells. They have also used collagen peptide and gelatin to successfully lower the glucose levels of diabetic mice to a normal level. Fish collagen is also being studied for usefulness in regenerative medicine.

The global collagen peptide and gelatin market holds massive potential for emerging nations, according to the European Nutraceutical Association, according to which 38.6% of deaths in Brazil, India, and China are caused due to lack of proper nutrition. The global collagen peptide and gelatin market’s products do not come without their own risks though; measures always have to be taken against the unknown transfer of diseases. There is also the concern of some cultures not accepting gelatin and collagen peptide products that are made from particular sources.

Despite these restraints, we can therefore conclude that the global collagen peptide and gelatin market, while in its nascent stage still, is showing positive signs and holds high promise in food and beverages as well as medical research.